http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021300950-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2403aad8bbbf284fed86d63332054c16
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02
filingDate 2021-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4d87d46e8d0cb6257d851e555f0247d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e084205b13c18121d9ceff65ff1dc2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_315b3313bbbd9a94f957576a493e6db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_219b5b861da1f2cd0948367c12c9533a
publicationDate 2021-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021300950-A1
titleOfInvention Solid state forms of ixazomib citrate
abstract The present disclosure encompasses solid state forms of Ixazomib Citrate and pharmaceutical compositions thereof. Also disclosed are processes for preparation of Ixazomib Citrate.
priorityDate 2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25183872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420444013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12564590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449151182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158332533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420321610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431904250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421305437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69037110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56844015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40461270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420870163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140778535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458077990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426117682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421888096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6553875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433585224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458240200

Total number of triples: 55.